This dual-action mechanism makes theranostics a powerful tool in fighting cancers that are hard to find or treat with ...

Radiopharm Theranostics Limited targets oncology with radiotherapeutics like Lu-RAD204 for NSCLC. Key 2025 data signals potential growth. Read why RADX stock is a Hold.

Related: Siemens Healthineers targeting theranostics, providers for growth In a July 2024 report, the journal Lancet Public Health describes how 17 cancer types have steadily increased in ...

Established in 2022, the Lancet Oncology Commission on Radiotherapy and Theranostics was led by the IAEA and includes experts from 44 academic institutions and medical centres across 23 different ...

This year, the Outpatient Theranostics Center at UCLA Health celebrates its first anniversary of many. UCLA Health is celebrating one year of treating patients with advanced prostate, thyroid and ...

Siemens Healthineers is positioning itself to benefit from the growing demand for theranostics by partnering with healthcare providers to provide more than equipment. Theranostics, which combines ...

Here, Professor Marie-Laure Yaspo, Chief Scientific Officer at Alacris Theranostics, discusses her work on molecular tumour profiling, and how MGI’s technology has assisted in acceleration of ...